January 24, 2025
Trump administration moves to restrict mifepristone access and defund Title X clinics
Trump opens FDA review of abortion pill while proposing Title X funding restrictions
📋Public Policy✊Civil Rights
FDA opened formal review of mifepristone's 2000 approval in Feb. 2025 at anti-abortion groups' request
No FDA decision made yet—review process typically takes months to years
HHS proposed reinstating Title X rules eliminating funding for clinics providing abortion referrals
Similar 2019 Trump rules caused Planned Parenthood to exit Title X, cutting 40% of program capacity
3.6 million low-income patients rely on Title X for family planning services annually
Over 6 million Americans have used mifepristone for medication abortion since 2000 approval
All proposed actions face required comment periods and likely court challenges
📋Public Policy✊Civil Rights
Test Your Knowledge
10
Q1
Morning Consult poll: ___ % of women ages 18-34 oppose the rollback.
Q2
FDA rule now requires in-person pickup of medication abortion pills, ending:
Q3
California enacted SB 1330 to stockpile how many years of mifepristone supply?
Q4
Fox News chyron called the new policy a victory for:
Q5
Planned Parenthood launched a text-bank campaign titled:
5 more questions available
Upgrade to Premium to access all practice questions and unlock advanced quiz features.
Upgrade to PremiumThese questions are part of the Trump administration moves to restrict mifepristone access and defund Title X clinics topic. Master this topic by completing the quiz or exploring each question in detail.
Ready to test your knowledge?
Take the full quiz to master this topic and track your progress.
Start QuizPeople, bills, and sources
FDA Commissioner
Agency head
HHS Secretary Robert F. Kennedy Jr.
Cabinet secretary
Alliance Defending Freedom
Conservative legal group
Planned Parenthood
Healthcare provider network
State attorneys general
State legal officials